(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 10.5% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.48%.
Twist Bioscience's revenue in 2025 is $362,273,000.On average, 4 Wall Street analysts forecast TWST's revenue for 2025 to be $22,622,067,472, with the lowest TWST revenue forecast at $22,574,985,950, and the highest TWST revenue forecast at $22,666,734,556. On average, 4 Wall Street analysts forecast TWST's revenue for 2026 to be $26,549,269,974, with the lowest TWST revenue forecast at $26,163,442,941, and the highest TWST revenue forecast at $26,916,143,676.
In 2027, TWST is forecast to generate $31,011,934,242 in revenue, with the lowest revenue forecast at $30,772,603,174 and the highest revenue forecast at $31,251,265,310.